AERIE PHARMACEUTICALS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Revenues, net
Product revenues, net
Licensing revenues
Total revenues, net
Cost of goods sold
Costs and expenses:
Cost of goods sold
Selling, general and administrative
Pre-approval commercial manufacturing
Total operating expenses
Total costs and expenses

Loss from operations
Other expense, net
Loss before income taxes
Income tax expense (benefit)
Net loss
Unrealized (loss) gain on available-for-sale investments
Comprehensive loss
Net loss per common share - diluted (in dollars per share)
Net loss per common share - basic (in dollars per share)
Weighted average number of common shares outstanding—diluted (in shares)
Weighted average number of common shares outstanding—basic (in shares)

Comments